CanSino Biologics Inc.
Works in Infectious disease · Neurology · Respiratory
CanSino Biologics Inc. is a clinical trial sponsor. It has 14 active clinical trials with 7,870 planned participants, in Infectious disease, Neurology and Respiratory. Since 2021 it has completed 23 trials and stopped 3 early.
Trial track record · since 2021
Pipeline · 14 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about CanSino Biologics Inc
CanSino Biologics Inc is lead sponsor of 14 active clinical trials on ClinicalTrials.gov, with 7,870 planned participants, in Infectious disease, Neurology, Respiratory. Since 2021 it has completed 23 trials and stopped 3 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with CanSino Biologics Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-08.
Approve Suite is not affiliated with CanSino Biologics Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.